AbbVie 2014 Annual Report Download - page 157

Download and view the complete annual report

Please find page 157 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 182

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182

13NOV201221352027
2014 Grants of Plan-Based Awards
................................................................................................................................................................................................................................................................................................................................................................................................
The following table summarizes the AbbVie equity awards granted under the AbbVie 2013 Incentive Stock
Program to the NEOs during 2014.
R. Gonzalez 02/20/14 162,960 $8,379,403(4)
02/20/14 281,030(5) $51.42 $51.86 2,762,525(6)
M. Severino 06/02/14 141,625 7,710,065(4)
06/02/14 74,309(5) 54.44 54.15 734,916(6)
C. Alban 02/20/14 47,260 2,430,109(4)
02/20/14 81,500(5) 51.42 51.86 801,145(6)
L. Schumacher 02/20/14 54,590 2,807,018(4)
02/20/14 94,140(5) 51.42 51.86 925,396(6)
W. Chase 02/20/14 53,770 2,764,853(4)
02/20/14 92,740(5) 51.42 51.86 911,634(6)
(1) During 2014, each of the NEOs participated in the AbbVie Performance Incentive Plan. The annual cash incentive
award earned by the NEO in 2014 under the plan is shown in the Summary Compensation Table in the column
captioned ‘‘Non-Equity Incentive Plan Compensation.’’ No future pay-outs will be made with respect to the 2014
awards under the plan. The plan is described in greater detail in the section of this proxy statement captioned
‘‘Compensation Discussion and Analysis—Compensation Plan Elements—Short-Term Incentives.’’
(2) These are performance-vested restricted stock awards that have a five-year term and vest upon AbbVie achieving a
minimum return on equity target, with no more than one-third of the award vesting in any one year. In 2014,
AbbVie reached its minimum return on equity target and one-third of each of the awards granted on February 20,
2014 vested on February 27, 2015. The return on equity targets are described in the section of this proxy
statement captioned ‘‘Compensation Discussion and Analysis—Compensation Plan Elements—Long-Term Incentives.’’
(3) Shares of outstanding restricted stock receive dividends at the same rate as all other stockholders. In the event of a
grantee’s death or disability, these awards are deemed fully earned. Upon a change in control, the treatment of
these awards is determined as described in the section of this proxy statement captioned ‘‘Potential Payments upon
Termination or Change in Control—Equity Awards.’’
(4) The grant date fair value of stock awards is determined by multiplying the number of shares granted by the
average of the high and low market prices of one share of AbbVie common stock on the award grant date.
(5) One-third of the shares of common stock covered by these options are exercisable after one year, two-thirds after
two years, and all after three years. The options vest in the event of the grantee’s death or disability. Upon a
change in control, the treatment of these awards is determined as described in the section of this proxy statement
captioned ‘‘Potential Payments upon Termination or Change in Control—Equity Awards.’’ Under the AbbVie 2013
Incentive Stock Program, these options have an exercise price equal to the average of the high and low market
prices (rounded up to the next even penny) of one share of AbbVie common stock on the date of grant. These
options do not contain a replacement option feature.
(6) The grant date fair value of option awards is determined as of the option grant date using a Black-Scholes stock
option valuation model. The assumptions used to determine the grant date fair value are described in footnote (3)
to the Summary Compensation Table.
2015 Proxy Statement 37
Estimated
Estimated Future Future All Other
Payouts Under Payouts Option Exercise
Non-Equity Under Equity Awards: or Base Closing Grant Date
Incentive Plan Incentive Numbers of Price of Market Fair Value
Awards(1) Plan Awards Securities Option Price on of Stock
Grant Target Maximum Target Underlying Awards Grant and Option
Name Date ($) ($) (#)(2)(3) Options (#) ($/Sh.) Date Awards
EXECUTIVE COMPENSATION